Frequently Asked Questions

Enbiosis uses its Digital Twin & AI Powered Nutraceutical Formulation Engine to model the gut microbiome and design condition-specific, food-grade nutraceutical formulations, which it licenses to OTC, supplement, food and beverage brands. Each formulation is simulated with digital twin technology and evaluated in clinical studies. Enbiosis formulations are licensed under the “Powered by Enbiosis” framework.

No. Enbiosis uses its Digital Twin & AI Powered Nutraceutical Formulation Engine to model the gut microbiome and design condition-specific, food-grade nutraceutical formulations, which it licenses to OTC, supplement, food and beverage brands. Microbiome analysis and personalised nutrition for clinics, laboratories, telehealth providers and pharmacies are offered under Enbioma, a separate brand.

Enbioma is a separate brand with its own business and its own buyers: clinics, laboratories, telehealth providers and pharmacies. It is not an Enbiosis product or platform. The two brands are connected only at company level: Enbioma is operated by Enbiosis Biotechnology Limited.

Enbiosis was founded in Türkiye in 2019. In January 2021 the company expanded to the United Kingdom, where Enbiosis Biotechnology Limited was incorporated in England and Wales (company number 13111010). Its registered office is in London. Today Enbiosis has offices in Türkiye and the United Kingdom. en-TEAR is sold in Türkiye through en-tear.com.tr.

Most formulations start with an ingredient. Enbiosis starts with the biology. Our Digital Twin and AI engine models the gut microbiome, identifies the disrupted pathways, and works backwards to determine the precise food-grade inputs needed. The result is a formulation with a defined biological purpose, not a generic blend.

The gut microbiome is a community of trillions of microorganisms in the digestive system that influences metabolism, immune function, brain health, hormonal balance, and more.

The gut microbiome is one of the body’s most powerful regulatory systems. By targeting it, we can address health conditions across multiple body systems, from metabolic and brain health to immune function, skin, and eye health.

Yes. Diet, lifestyle, environment, and genetics all shape the gut microbiome differently across regions and populations. This means an ingredient that works well in one population may produce different results in another. Enbiosis uses computational modelling to account for this variability, designing formulations that work across diverse microbiome profiles rather than a single population average.

Our Digital Twin and AI engine runs simulations across thousands of real human microbiome profiles to identify which pathways are disrupted in a specific health condition, then works backwards to determine the most targeted food-grade ingredients.

An AI-powered tool that works backwards from a target metabolite to identify the minimal set of food-grade ingredients that gut bacteria can naturally convert into the required compounds.

A digital twin is a virtual model of the gut microbiome. Before we select a single ingredient, we run thousands of simulations inside this model to understand how different combinations will behave in the gut. This means every formulation we design has been tested computationally before it is tested clinically.

All ingredients are food-grade and permitted by EFSA and FDA.

Enbiosis formulations are studied in stages, from pilot studies to randomised trials. Randomised studies of Enbiosis formulations are ongoing in six health areas and registered on ClinicalTrials.gov: eye, metabolic, weight management, gastrointestinal, skin and men’s health. Results will be shared when the studies are completed.

Randomised studies of Enbiosis formulations are ongoing in six health areas and registered on ClinicalTrials.gov: eye, metabolic, weight management, gastrointestinal, skin and men’s health. Results will be shared when the studies are completed.

Enbiosis supports gut microbiome pathways across a broad range of health areas, including metabolic, cognitive and mental, neurological, immune, cardiovascular, skin, and autoimmune, as well as wellness goals such as eye health, longevity, oral health, and hormonal balance.

Enbiosis formulations support gut microbiome pathways associated with specific health areas. They are not intended to diagnose, treat, cure, or prevent any disease. Please consult a healthcare professional for personal health concerns.

Yes. en-TEAR is an Enbiosis smart supplement built on the gut-eye axis and is on sale in Türkiye.

en-TEAR is an Enbiosis smart supplement built on the gut-eye axis: a food supplement in sachets, taken once a day as an 8-week programme. It is sold in Türkiye at en-tear.com.tr. A pilot study of the finished formula has been completed (NCT07148271), and the finished formula is being studied in an ongoing, registered, placebo-controlled randomised trial (NCT07453212). The results of the randomised trial will be shared when it is completed.

Enbiosis smart supplements are the company’s own products, the en- family: en-TEAR, en-JOY&FIT, en-CLEAR and en-MASCULINE. Each is a ready-made formula designed with digital twin technology and AI for a specific health area, not a supplement personalised for an individual. “Smart” refers to this design process, not to a health effect. The term is a category label: the products keep their legal name, such as food supplement.

Enbiosis has developed formulations targeting gut microbiome pathways associated with brain health and cognitive function the gut-brain axis. Clinical research in this area is ongoing.

Enbiosis has developed formulations targeting gut microbiome pathways associated with skin barrier function and hydration. Clinical research in this area is ongoing.

Enbiosis formulations are compatible with capsules & powders, dairy & fermented products, functional foods, and functional beverages (wellness drinks, metabolic shots). Format compatibility is evaluated per formulation.

The main business of Enbiosis is licensing its formulations to food, beverage and supplement brands for use in their own products. The exception today is en-TEAR, which is sold directly to consumers in Türkiye through en-tear.com.tr.

Efficacy timelines vary depending on the formulation and health area. For detailed information, please visit enbiosis.com or contact our team directly.

All Enbiosis ingredients are food-grade and permitted by EFSA and FDA.

Enbiosis is a formulation platform. Our blends vary from formulation to formulation, so we are unable to provide Vegan, Halal, or Kosher declarations for individual blends. These certifications are managed through our Licensing Partners. For more information, please visit enbiosis.com or contact our team directly.

Enbiosis offers two partnership models: Formulation Licensing and Nutraceutical Sales. For detailed information, please complete the form or contact our team directly.

Licences are available globally, including the US, Latin America, Europe, GCC/Middle East, and Asia Pacific.

Yes. Exclusivity is available by formulation, product category, and territory.

Enbiosis formulations are available for licensing or as a premix for OTC, supplement, food and beverage brands looking to expand their product portfolio. en-JOY&FIT, en-CLEAR and en-MASCULINE are in development and open to licensing. Distribution partners interested in en-TEAR as a finished product can contact our team. Get in touch to explore the right option for your business.

“Powered by Enbiosis” is the framework under which Enbiosis licenses its formulations to OTC, supplement, food and beverage brands. Licences are granted by formulation, category and territory, with exclusivity available.

Enbiosis’s technology is supported by multiple layers of scientific and regulatory validation. The platform has received the UK Tech Rocketship Award Gold, with research published in Q1 peer-reviewed journals. Formulations are built exclusively from EFSA and FDA permitted ingredients, manufactured to GMP standards, and supported by active patent applications.

For partnership, licensing, or general enquiries please complete the form or contact our team directly